v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Notes Receivables from Stockholders
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income/(Loss)
Beginning balance (in shares) at Dec. 31, 2023 [1]   15,035,467        
Beginning balance at Dec. 31, 2023 $ 122,600 $ 2 [1] $ (10,111) $ 1,838,499 $ (1,704,076) $ (1,714)
Increase (Decrease) in Stockholders' Equity            
Adjustment of transaction costs related to Business Combination (2,372)     (2,372)    
Issuance of common stock for options exercised (in shares) [1]   2,770        
Issuance of common stock for options exercised 1,454     1,454    
Cancellation of common stock (in shares) [1]   (29,073)        
Stock-based compensation 17,196     17,196    
Tax withholding upon vesting of restricted stock units (1,372)     (1,372)    
Shares issued for vested restricted stock units (in shares) [1]   101,810        
Shares issued for vested restricted stock units 1     1    
Vesting of common stock issued via notes receivable from stockholders (8)   (865) 857    
Settlement of notes receivable from stockholders 0   1,846 (1,846)    
Net loss (92,857)       (92,857)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax 266         266
Ending balance (in shares) at Jun. 30, 2024 [1]   15,110,974        
Ending balance at Jun. 30, 2024 44,908 $ 2 [1] (9,130) 1,852,417 (1,796,933) (1,448)
Beginning balance (in shares) at Mar. 31, 2024 [2]   15,111,574        
Beginning balance at Mar. 31, 2024 76,290 $ 2 [2] (10,976) 1,844,859 (1,755,568) (2,027)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock for options exercised (in shares) [2]   353        
Issuance of common stock for options exercised 1,435     1,435    
Cancellation of common stock (in shares) [2]   (17,194)        
Stock-based compensation 8,053     8,053    
Tax withholding upon vesting of restricted stock units (84)     (84)    
Shares issued for vested restricted stock units (in shares) [2]   16,241        
Shares issued for vested restricted stock units 0          
Settlement of notes receivable from stockholders 0   1,846 (1,846)    
Net loss (41,365)       (41,365)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax 579         579
Ending balance (in shares) at Jun. 30, 2024 [1]   15,110,974        
Ending balance at Jun. 30, 2024 $ 44,908 $ 2 [1] (9,130) 1,852,417 (1,796,933) (1,448)
Beginning balance (in shares) at Dec. 31, 2024 15,168,795 15,168,795        
Beginning balance at Dec. 31, 2024 $ (58,170) $ 2 (9,158) 1,863,288 (1,910,366) (1,936)
Increase (Decrease) in Stockholders' Equity            
Gain on troubled debt restructuring (see Note 10) 210,044     210,044    
Tax effect on gain on troubled debt restructuring (4,721)     (4,721)    
Stock-based compensation 9,060     9,060    
Tax withholding upon vesting of restricted stock units (in shares)   (63,563)        
Tax withholding upon vesting of restricted stock units (373)     (373)    
Shares issued for vested restricted stock units (in shares)   168,913        
Vesting of common stock issued via notes receivable from stockholders 3   (2) 5    
Net loss (86,827)       (86,827)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax $ 7,541         7,541
Ending balance (in shares) at Jun. 30, 2025 15,274,145 15,274,145        
Ending balance at Jun. 30, 2025 $ 76,557 $ 2 (9,160) 2,077,303 (1,997,193) 5,605
Beginning balance (in shares) at Mar. 31, 2025   15,188,035        
Beginning balance at Mar. 31, 2025 (102,145) $ 2 (9,160) 1,867,649 (1,960,923) 287
Increase (Decrease) in Stockholders' Equity            
Gain on troubled debt restructuring (see Note 10) 210,044     210,044    
Tax effect on gain on troubled debt restructuring (4,721)     (4,721)    
Stock-based compensation 4,617     4,617    
Tax withholding upon vesting of restricted stock units (in shares)   (53,884)        
Tax withholding upon vesting of restricted stock units (286)     (286)    
Shares issued for vested restricted stock units (in shares)   139,994        
Net loss (36,270)       (36,270)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax $ 5,318         5,318
Ending balance (in shares) at Jun. 30, 2025 15,274,145 15,274,145        
Ending balance at Jun. 30, 2025 $ 76,557 $ 2 $ (9,160) $ 2,077,303 $ (1,997,193) $ 5,605
[1] Periods have been adjusted to reflect the 1-for-50 reverse stock split on August 16, 2024. See Note 1 Organization and Nature of the Business - Reverse Stock Split, for additional information.
[2] Periods have been adjusted to reflect the 1-for-50 reverse stock split on August 16, 2024. See Note 1 Organization and Nature of the Business - Reverse Stock Split, for additional information.